What Happened?
Alameda, CA-based Alveo-Technologies Appointed Ron Chiarello as Chief Executive Officer
About the Company
At Alveo we understand the importance of access to cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases. With an initial focus on acute respiratory infections including COVID-19, Flu A/B and RSV, Alveo`s agile and dynamic molecular diagnostic platform, be.well™, can be adapted to detect a wide range of diseases, bacteria, and other pathogens that threaten public health, across all modalities. We believe increased access to real-time test results will transform the way individuals, healthcare providers and public health professionals identify and manage infectious diseases. With be.well™, we will Know Sooner, Act Faster™.
About the Person
Ron Chiarello is Chief Executive Officer at Alveo Technologies. Previously, Ron held various senior HR leadership roles in the industry.
Info Source
News
Short Profile